Pluvia Biotech

📍 Bergen, Norway🗓 Founded 2015👥 9 employees💰 Last funded Jun 2025
Biotechnology Research🌐 pluviabiotech.com
Website LinkedIn
Pluvia Biotech is a spin-out from the University of Bergen (Norway) dedicated to developing "first in class" oral pharmacological chaperones for the treatment of Phenylketonuria (PKU). Through pioneering research and development, Pluvia Biotech aims to provide PKU patients with the opportunity to live life without the dietary constraints imposed by the condition. The company has significant momentum moving its lead compound towards clinical Proof of Concept.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Norway
1
Frequently asked questions
Who invested in Pluvia Biotech?
Pluvia Biotech has 1 investors on record on gritt.io and 1 late-stage investors.
When did Pluvia Biotech last raise funding?
The most recent investment in Pluvia Biotech recorded on gritt.io was in June 2025.
When was Pluvia Biotech founded?
Pluvia Biotech was founded in 2015.
What industry is Pluvia Biotech in?
Pluvia Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pluvia Biotech based?
Pluvia Biotech is headquartered in Bergen, Norway.